Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
Metformin is increasingly being used in women with type 2 diabetes during pregnancy. Little data exist on the benefits and harms of metformin use on pregnancy outcomes. We found no significant difference in the primary composite neonatal outcome between the two groups. The most common adverse event reported was gastrointestinal.

Related Post